Nicole Broussard

Field Access Manager, Rare Disease (HAE/LSD/HEM)

Takeda

Apr 2025 - Current (1 year 4 months)

Lead access strategy execution for rare and ultra-rare therapies, aligning providers, health systems, specialty pharmacies, and infusion sites to remove reimbursement and operational barriers to care. Translate field access intelligence into enterprise recommendations on medical benefit policy impacts, buy-and-bill dynamics, specialty pharmacy routing, and site-of-care readiness. Partner cross-functionally with Market Access, Patient Services, Medical, and Commercial teams to strengthen compliant access pathways, escalation frameworks, and patient affordability navigation. Support launch readiness for pipeline assets by identifying coverage risks, operational bottlenecks, and policy-driven barriers that may impact time-to-therapy. Enabl

Compliance Monitoring Specialist (Consultant)

MBO Partners

Jan 2025 - May 2025 (5 months)

MBO PARTNERS Compliance Monitoring Specialist (Consultant) | Jan 2025–May 2025 | Remote Conducted compliance monitoring of speaker programs, field engagements, and patient education events, assessing adherence to FDA guidance, PhRMA Code, and internal SOPs. Delivered audit-ready documentation and risk-based insights to legal/compliance leaders, strengthening governance and corrective action planning. Identified emerging field risk patterns and recommended pragmatic process improvements to reduce exposure while maintaining commercial effectiveness.

Parent Co-Leader

McGovern Medical School

Aug 2024 - Dec 2024 (5 months)

Co-facilitated an evidence-based program supporting families navigating the transition to adulthood for neurodiverse young adults (CBT/ACT/MI-informed framework).

Counsel

Johnson Johnson

Dec 2023 - Sep 2024 (10 months)

Served as strategic counsel to cross-functional leaders designing and operating patient support programs that help patients start and stay on therapy. Advised on specialty pharmacy contracting, FMV/AKS considerations, patient support workflows, and governance for HUB vendors and field roles (FRMs, nurse teams, etc.). Supported clinical trial-to-commercial transition strategies, free goods frameworks, and patient assistance program compliance controls. Reviewed promotional/non-promotional materials and executive communications; strengthened rules of engagement and SOPs to ensure compliant execution.

Director - Corporate Compliance

FUJIFILM DIOSYNTH BIOTECHNOLOGIES

Mar 2022 - Sep 2022 (7 months)

Led U.S. corporate compliance strategy across multiple manufacturing sites, partnering with leadership to implement consistent governance, training, and risk controls. Managed enterprise compliance domains including data protection, anti-corruption, and risk management aligned with global standards. Built cross-site collaboration and delivered targeted education to improve compliance maturity and operational accountability.

Associate Director, Value, Access & Payment (VAP) / Patient Services Compliance & Quality Assurance

Bristol Myers Squibb

Nov 2020 - Mar 2022 (1 year 5 months)

Led compliance oversight for VAP and Patient Services, including HUB operations, patient assistance, and co-pay support—ensuring scalable, audit-ready governance. Partnered with Legal, Privacy, Audit, Data Governance, Market Access, HEOR, and Commercial Ops to resolve complex compliance scenarios and enable access goals. Contributed to enterprise risk assessments and audit planning; drove process improvements that strengthened controls without slowing patient access. Built training and guidance for access and patient services stakeholders to ensure consistent, compliant operations.

Field Reimbursement Manager (Southwest) - Rare Disease Business Unit

Pfizer

Mar 2019 - Dec 2020 (1 year 10 months)

Served as reimbursement and access strategist for rare disease brands across major academic centers and health systems; enabled compliant access pathways and issue resolution. Partnered with revenue cycle stakeholders on medical/pharmacy benefit reimbursement, HUB workflows, and coverage navigation to accelerate therapy initiation. Recognized with multiple W.E. Upjohn Awards for impact, execution, and customer partnership. Products: Genotropin, Somavert, Elelyso, Vyndaqel/Vyndamax (product launch 2019) Institutions: UT Southwestern, University of Colorado, Banner Health, Mayo (AZ), Methodist (Houston), MD Anderson, UTMB, Baylor Scott & White, Ochsner, UT Health Science Center - Houston; UT Health Science Center - San Antonio, Baylor Col

Rare Disease Reimbursement Specialist - Rare Disease BU

Pfizer

Feb 2015 - Feb 2019 (4 years 1 month)

Built long-term institutional relationships across TX/LA; delivered access education, coding/reimbursement support, and HUB enablement for complex rare disease therapies. Collaborated cross-functionally to execute regional payer strategy and surface field insights relevant to coverage and operational barriers. Products: Genotropin, Somavert, Elelyso Institutions: MD Anderson, Methodist (Houston), Baylor College of Medicine, Texas Children's Hospital, UTMB, Ochsner, UT Health Science Center - Houston; UT Health Science Center - San Antonio, LSU (New Orleans/Baton Rouge), Driscoll Children's Hospital.

N

Advisor | Legal, Compliance & Access Governance

Nicole Broussard Attorney and Counselor at Law

May 2006 - Current (20 years 3 months)

Remote Advise pharma/biotech leaders on patient access strategy, legal risk, and governance across commercialization and patient support models (medical benefit, HUB/PSP, affordability programs, specialty pharmacy). Lead Medical-Legal-Regulatory (MLR) review of promotional and non-promotional materials, message maps, and field enablement tools for sales, access, HEOR, and medical teams. Counsel on FDA promotional considerations, PhRMA/AdvaMed Code, fraud and abuse risk (AKS/FCA), and compliant engagement models with HCPs, SPs, vendors, and patient-facing programs. Provide privacy and data governance leadership across HIPAA/PHI/PII and broader data protection frameworks (GDPR/CCPA), including program design and risk mitigation. Develop

A

EARLY CAREER

AstraZeneca Novartis IQVIA Pharmacy Management Services

Jul 1998 - Feb 2005 (6 years 8 months)

Built foundational leadership experience across commercial execution, national training, reimbursement education, infusion operations, and specialty pharmacy environments, with early promotion into national training and leadership roles.

About

Detail

Timeline

Résumé